Guggenheim Capital’s OmniAb OABI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-26,028
Closed -$97.6K 1918
2024
Q2
$97.6K Sell
26,028
-7,312
-22% -$33.3K ﹤0.01% 1829
2024
Q1
$181K Sell
33,340
-427
-1% -$2.46K ﹤0.01% 1809
2023
Q4
$208K Sell
33,767
-12
-0% -$59 ﹤0.01% 1798
2023
Q3
$175K Sell
33,779
-57
-0.2% -$304 ﹤0.01% 1763
2023
Q2
$170K Sell
33,836
-61
-0.2% -$247 ﹤0.01% 1795
2023
Q1
$125K Buy
33,897
+2,659
+9% +$10K ﹤0.01% 1864
2022
Q4
$112K Buy
+31,238
New +$164K ﹤0.01% 1863

Other funds holding OABI

Guggenheim Capital's OABI Position: Q3 2024 in Review

Guggenheim Capital sold out of OmniAb (OABI) in Q3 2024, closing a stake of 26,028 shares — an estimated $97.6K sold.

Guggenheim Capital first reported a position in OABI in Q4 2022 and held it in 7 quarters. The position peaked at $208K in Q4 2023. 165 funds tracked by Wall St. Rank hold OABI as of Q3 2024.

  • Guggenheim Capital reported no remaining OmniAb position as of Q3 2024 after selling out during the quarter.
  • Guggenheim Capital sold 26,028 OmniAb shares in Q3 2024, an estimated $97.6K.
  • Guggenheim Capital first reported a position in OmniAb in Q4 2022 and held it in 7 quarters.
  • Guggenheim Capital's OmniAb position peaked at $208K in Q4 2023.
  • 165 funds tracked by Wall St. Rank held OmniAb as of Q3 2024.

Based on Guggenheim Capital's 13F filing for Q3 2024, filed 13 Nov 2024.